American Research & Management Co. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
American Research & Management Co. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2022$3,899,000
-10.6%
51,290
-0.6%
1.08%
-3.9%
Q2 2022$4,362,000
-5.2%
51,602
-1.6%
1.12%
+10.6%
Q1 2022$4,600,000
-4.3%
52,418
-4.6%
1.01%
-2.5%
Q4 2021$4,807,000
+6.7%
54,960
-0.3%
1.04%
-0.1%
Q3 2021$4,507,000
-11.3%
55,110
-1.0%
1.04%
-10.2%
Q2 2021$5,081,000
+7.2%
55,685
+0.4%
1.16%
+1.4%
Q1 2021$4,741,000
-11.0%
55,469
-1.7%
1.14%
-17.5%
Q4 2020$5,329,000
+8.5%
56,431
-0.1%
1.39%
-3.4%
Q3 2020$4,912,000
-0.6%
56,481
-0.2%
1.44%
-4.3%
Q2 2020$4,942,000
+5.0%
56,581
-0.9%
1.50%
-16.1%
Q1 2020$4,706,000
-15.3%
57,074
-2.7%
1.79%
+8.7%
Q4 2019$5,553,000
+7.2%
58,647
-1.6%
1.64%
+5.5%
Q3 2019$5,179,000
-5.2%
59,597
-0.4%
1.56%
-4.7%
Q2 2019$5,463,000
-6.2%
59,827
-1.3%
1.63%
-1.7%
Q1 2019$5,827,000
+14.6%
60,607
+2.3%
1.66%
-3.0%
Q4 2018$5,086,000
+0.1%
59,268
+0.5%
1.71%
+13.7%
Q3 2018$5,082,000
+16.5%
58,988
+2.1%
1.51%
-0.5%
Q2 2018$4,362,000
-5.6%
57,749
+1.1%
1.52%
-0.1%
Q1 2018$4,619,000
-5.1%
57,124
-1.4%
1.52%
+1.0%
Q4 2017$4,865,000
-3.0%
57,949
-0.8%
1.50%
-7.5%
Q3 2017$5,014,000
+2.9%
58,3990.0%1.62%
+1.4%
Q2 2017$4,875,000
+12.1%
58,399
-0.3%
1.60%
+3.5%
Q1 2017$4,348,000
+1.4%
58,549
-0.5%
1.55%
+5.3%
Q4 2016$4,287,000
-12.3%
58,849
-5.0%
1.47%
-17.6%
Q3 2016$4,890,000
-2.9%
61,934
+1.4%
1.78%
-7.9%
Q2 2016$5,038,000
+12.6%
61,057
-1.1%
1.94%
+3.1%
Q1 2016$4,474,000
-15.7%
61,758
+0.2%
1.88%
-17.1%
Q4 2015$5,305,000
-8.1%
61,657
-1.8%
2.27%
-10.2%
Q3 2015$5,770,000
-6.2%
62,774
+0.3%
2.52%
+1.0%
Q2 2015$6,154,000
-0.1%
62,581
+0.2%
2.50%
-0.4%
Q1 2015$6,159,000
+5.7%
62,462
-0.7%
2.51%
+16.5%
Q4 2014$5,829,000
-1.6%
62,910
-0.1%
2.15%
+0.7%
Q3 2014$5,926,000
+2.1%
62,960
-1.8%
2.14%
+6.1%
Q2 2014$5,802,000
+5.5%
64,087
-0.9%
2.02%
+3.0%
Q1 2014$5,497,000
+4.1%
64,657
-1.6%
1.96%
+3.8%
Q4 2013$5,281,000
+4.4%
65,699
-0.4%
1.88%
-5.9%
Q3 2013$5,058,000
+8.0%
65,934
-0.5%
2.00%
+6.5%
Q2 2013$4,683,00066,2351.88%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders